Akero Therapeutics, Inc. of South San Francisco, CA, a company, filed a Form D exempt-offering notice with the SEC on 2018-12-18. The offering totals $45.5M, of which $45.5M was reported sold. Industry: Other Health Care.
| Name | Role | Location |
|---|---|---|
| Kevin Bitterman | Director | Cambridge, MA |
| Andrew Cheng | Director | South San Francisco, CA |
| Mark Iwicki | Director | Arlington, MA |
| Aaron Kantoff | Director | Rockville, MD |
| Aaron Royston | Director | Cambridge, MA |
| Graham Walmsley | Director | San Francisco, CA |
| Andrew Cheng | Executive Officer | South San Francisco, CA |
| Jonathan Young | Executive Officer | St Peter Port, Y7 |